Rheumatoid Arthritis PBMC
About: Rheumatoid Arthritis PBMC samples are collected from clinically confirmed rheumatoid arthritis (RA) donors and cryopreserved. These PBMCs are ideal for analyzing T and B cell function, monocyte behavior, and cytokine response relevant to autoimmune activity.
| Lot # | Condition | Cell Count (M) | Race/Ethnicity | Age | Gender | Country of Collection | Medications | Vials | Price | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| 75247 | Rheumatoid Arthritis | 10M | Caucasian | 63 | Male |
Enbrel 50mL inj QW Atorvastatin 10mg QD Trazadone PRN
|
5 | $530.00 | ||
| 71958 | Rheumatoid Arthritis | 10M | Hispanic/Latino | 75 | Female | 3 | $530.00 | |||
| 73986 | Rheumatoid Arthritis | 10M | Caucasian | 67 | Female |
Vitamin D/2000IU/QD - po Paxil/60mg/QD - po Omeprazole/20mg/QD - po Aspirin/325mg/QD - po Leflunomide/10mg/BID - po Metoprolol/100mg/QD - po Xanax/1mg/QD - po PRN Atorvastatin/10mg/QHS - po Losarton 50 mg QD Diclofenac 70 mg QD Amlodipine 5 mg BID
|
2 | $530.00 | ||
| 75197 | Rheumatoid Arthritis | 5M | Hispanic/Latino | 75 | Female |
Methotrexate
|
34 | |||
| 76313 | Rheumatoid Arthritis | 5M | Hispanic/Latino | 70 | Female |
Methotrexate
|
15 | |||
| 77630 | Rheumatoid Arthritis | 5M | Hispanic/Latino | 73 | Female |
Anti-TNF (adalimumab or biosimilar)
|
5 | |||
| 73087 | Rheumatoid Arthritis | 10M | African American | 57 | Female |
Naproxen PRN Lidocaine Pain Patches Ibuprofen PRN Propranolol 80 mg QD Lisinopril 10 mg QD Omeprazole 20 mg QD Multivitamin QD Kenalog Q 3 months Amlodipine Folic Acid Rescue Inhaler
|
3 | $530.00 | ||
| 75196 | Rheumatoid Arthritis | 5M | Hispanic/Latino | 67 | Female |
Methotrexate
|
10 | |||
| 72860 | Rheumatoid Arthritis | 10M | Hispanic/Latino | 66 | Female |
Levothyroxine 88mg Maribagrone - Marabetric 50mgs Gonavia - 100 mgs (johnavia) Levothyroxines 100mcgs Generic Lunesta 3 mg
|
2 | $530.00 | ||
| 76306 | Rheumatoid Arthritis | 5M | Hispanic/Latino | 76 | Male |
Methotrexate
|
2 |
High-Quality Rheumatoid Arthritis PBMC for Research
Rheumatoid Arthritis Human PBMC products are sourced from donors clinically diagnosed with rheumatoid arthritis (RA) and processed under stringent conditions to support research. These cryopreserved peripheral blood mononuclear cells (PBMCs) enable studies on T and B cell function, monocyte behavior, cytokine responses, and gene expression relevant to autoimmune activity and therapeutic targets.
Product Features
- Research Use Only (RUO), cryopreserved PBMCs
- Clinically confirmed RA donors
- Available in cell counts ranging from 5 million to 2 billion
- Processed within 24 hours of collection
- Stored using CryoStor® CS10 freezing media
- IRB-approved protocols and electronic informed consent
- Screen LeukoLot™ available prior to bulk orders
De-identified Donor Data
- Verified RA diagnosis
- Donor demographics: age, sex assigned at birth, race/ethnicity
- Self-reported allergies and infectious disease history
- Additional RA-specific data available upon request
Applications
- Biomarker discovery and validation
- Drug screening and therapeutic development
- Immune pathway analysis in RA pathophysiology
- Transcriptomic and proteomic profiling
Quality and Compliance
- IRB-approved collections and protocols
- 21 CFR Part 11 – compliant e-consent system
- HIPAA-compliant donor data protection
Ordering & Shipping
Rheumatoid Arthritis PBMC samples are shipped on dry ice and available in custom aliquots. For international orders or regulatory requirements, please contact learnmore@sanguinebio.com to confirm documentation and compliance needs.
Protocols & Documentation
-
Download
PBMC Isolation from Whole Blood
Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.
-
Download
Immune Cell Isolation
Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.
-
Download
Choosing the Right PBMC Configuration
Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.
-
Download
Thawing Cryopreserved PBMC
Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
PBMC
Frequently Asked Questions
1 Answer
All our samples have self-reported infectious disease testing and verified clinical diagnosis. Many of our samples have the option of electronic medical records provided and our prospective collection offers the opportunity for patient reported outcomes and surveys. Learn more here. https://sanguinebio.com/patient-reported-outcomes-pro-surveys-questionnaires/
1 Answer
YES – Certificate of analysis is available upon request.
1 Answer
Lead times vary from ready to ship inventory to prospective studies.
1 Answer
International shipping is available. We also work with a number of distributors. Contact us to discuss options at learnmore@sanguinebio.com.
1 Answer
We have several ordering methods. You can order directly online with a PO or credit card or contact us to have a sales specialist help with your order. https://sanguinebio.com/request-quote/
1 Answer
You can request a quote on this page or contact us at learnmore@sanguinebio.com. https://sanguinebio.com/request-quote/
1 Answer
NO – no minimum order requirements.
1 Answer
For bulk pricing inquiries, please contact: LearnMore@sanguinebio.com
1 Answer
YES – Fresh leukopaks can be delivered same day in select locations. Often, leukopaks are shipped same day as collection, thus arriving next day.
1 Answer
Contact learnmore@sanguinebio.com for current inventory. The website states “over 150 verified-conditions from ready-to-ship to prospective collections.” View our ready to ship products: https://sanguinebio.com/products/?pro_inventory=inventory
1 Answer
YES – Matched samples across multiple matrices are available, including synovial fluid are available.
0 Answer
Ask a Question
Need a custom PBMC cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.